CME Group Inc. $CME Stock Sold by Bank Pictet & Cie Europe AG

Bank Pictet & Cie Europe AG cut its holdings in shares of CME Group Inc. (NASDAQ:CME) by 5.7% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 52,604 shares of the financial services provider’s stock after selling 3,205 shares during the period. Bank Pictet & Cie Europe AG’s holdings in CME Group were worth $13,781,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of CME. MBM Wealth Consultants LLC raised its stake in CME Group by 25.1% in the third quarter. MBM Wealth Consultants LLC now owns 2,339 shares of the financial services provider’s stock worth $613,000 after buying an additional 469 shares in the last quarter. Net Worth Advisory Group lifted its holdings in CME Group by 29.7% during the third quarter. Net Worth Advisory Group now owns 3,466 shares of the financial services provider’s stock worth $919,000 after buying an additional 793 shares during the period. Kenora Financial LLC purchased a new stake in CME Group during the third quarter worth $221,000. CWA Asset Management Group LLC boosted its position in CME Group by 0.7% during the 3rd quarter. CWA Asset Management Group LLC now owns 7,988 shares of the financial services provider’s stock valued at $2,093,000 after acquiring an additional 52 shares in the last quarter. Finally, CFS Investment Advisory Services LLC boosted its position in CME Group by 10.0% during the 3rd quarter. CFS Investment Advisory Services LLC now owns 4,301 shares of the financial services provider’s stock valued at $1,162,000 after acquiring an additional 391 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. TD Cowen lifted their price target on CME Group from $292.00 to $300.00 and gave the company a “buy” rating in a report on Monday, October 5th. Weiss Ratings upgraded CME Group from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. The Goldman Sachs Group decreased their price objective on CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a research note on Tuesday, June 30th. Barclays raised their price objective on CME Group from $270.00 to $281.00 and gave the company an “equal weight” rating in a research report on Wednesday, October 7th. Finally, Wall Street Zen upgraded CME Group from a “strong sell” rating to a “sell” rating in a research note on Saturday, October 3rd. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, CME Group presently has an average rating of “Hold” and a consensus target price of $292.94.

CME Group Stock Up 0.5%

CME traded up $1.52 during trading on Tuesday, hitting $295.05. The stock had a trading volume of 1,132,214 shares, compared to its average volume of 2,514,001. The company has a market capitalization of $106.09 billion, a PE ratio of 25.03, a PEG ratio of 3.80 and a beta of 0.24. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a 50 day simple moving average of $274.72 and a two-hundred day simple moving average of $270.56.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%. The business had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the prior year, the firm posted $2.96 earnings per share. The business’s quarterly revenue was up .8% on a year-over-year basis. On average, research analysts predict that CME Group Inc. will post 12.30 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 25th. Investors of record on Wednesday, September 9th were paid a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.8%. The ex-dividend date was Wednesday, September 9th. CME Group’s payout ratio is 44.11%.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Analysts expect third-quarter revenue of approximately $1.71 billion, up 11.4% year over year, and EPS of about $2.98. International trading volume is reportedly up 22%, while several analysts have raised their price targets ahead of the results. A beat could reinforce the recent positive momentum. CME Group earnings preview
• Positive Sentiment: CME plans to introduce cash-settled tungsten futures during the first half of 2027, subject to regulatory approval. The contract could benefit from rising demand for critical minerals and broaden CME’s metals product portfolio. CME tungsten futures launch
• Positive Sentiment: The exchange has begun adding Bitcoin Cash and Uniswap futures, offering institutional traders regulated tools to hedge or gain exposure to additional digital assets. The launches expand CME’s cryptocurrency derivatives franchise, although demand remains to be proven. CME Bitcoin Cash and Uniswap futures
• Neutral Sentiment: CME disclosed $460,000 in third-quarter lobbying focused on clearinghouse, derivatives, Treasury futures, digital-asset and tax regulations. The spending may help protect long-term market access, but it has little immediate earnings impact. CME lobbying update
• Negative Sentiment: The CFTC is asking a federal court to dismiss CME’s lawsuit concerning crypto perpetual futures. The unresolved regulatory dispute could delay or limit CME’s ability to expand in this product area. CFTC lawsuit involving CME perpetual futures
• Negative Sentiment: Recent filings show more insider sales than purchases, including sizable sales by Chairman and CEO Terrence Duffy. Although insider transactions do not necessarily reflect operating expectations, they may weigh modestly on sentiment. CME insider trading and institutional activity

Insider Buying and Selling

In other CME Group news, Director William R. Shepard purchased 293 shares of the firm’s stock in a transaction on Friday, September 25th. The stock was bought at an average cost of $268.76 per share, for a total transaction of $78,746.68. Following the completion of the purchase, the director owned 263,289 shares in the company, valued at $70,761,551.64. This represents a 0.11% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Terrence A. Duffy sold 15,000 shares of the firm’s stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $274.44, for a total value of $4,116,600.00. Following the completion of the sale, the chief executive officer directly owned 40,630 shares of the company’s stock, valued at approximately $11,150,497.20. This represents a 26.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by company insiders.

About CME Group

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.